For healthcare professionals only

News Extra

Two victims of diethylstilbestrol win lawsuit

BMJ 2002; 324 doi: (Published 08 June 2002) Cite this as: BMJ 2002;324:1354
  1. Alexander Dorozynski
  1. Paris

    Two women who developed cancer after their mothers took the drug diethylstilbestrol have won their case against the pharmaceutical company UCB Pharma.

    The company continued to market the drug until 1977, six years after it was found to be associated with an increase in vaginal cancer in girls and young women whose mothers had taken it, and six years after it was taken off the market in the United States. This is the first successful suit involving the drug in France.

    The court ordered the company to pay each of the women €15 244 (£9634; $13 994) as an interim payment, until full damages are …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription